Immucell Corp.
ICCC
Market Cap$61M
Close$
$6.58
3% upside
Current Fair Value
3% upsideUndervalued by 3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $61.00 Million |
|---|---|
| Enterprise Value | $1.47 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.26 |
| Beta | 0.31 |
| Outstanding Shares | 8,980,602 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.04 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | 2.71 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 4.09 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Immucell Corp.
CEO: Michael Brigham